FDA Drug and Style Approvals: Zelnorm, Taxotere, Merci Retriever, and Others

Aug. 26, 2007 — The U.S.Food and Drug Government (FDA) has approved tegaserod maleate for chronic idiopathic symptom, docetaxel in accumulation with doxorubicin and cyclophosphamide for node-positive tit individual, and loratadine/pseudoephedrine sulfate for over-crowding due to the common cold.
A style for removing thromboemboli in stroking patients (Merci Retriever) and a workstation to enhance mamma pictorial representation (Impax Mammography Diagnostic Workstation) have also been approved.
Tegaserod Maleate (Zelnorm) for Chronic Idiopathic Irregularity
On Aug. 23, the FDA approved a supplemental communication for tegaserod maleate (Zelnorm, made by Novartis Pharmaceuticals Corp.), allowing its use in the management of chronic idiopathic irregularity in patients younger than 65 assemblage.
The acceptance was based on the results of two 3-month, randomized, double-blind, placebo-controlled, multinational time period III clinical trials involving more than 2,600 patients.
Tegaserod was found to significantly modification the relative frequency of complete spontaneous bowel movements and provide assist from symptoms such as elbow grease, hard feces, incomplete remotion, infrequent defecation, bloating, and abdominal condition.
Docetaxel was previously approved in the artistic style of locally advanced or metastatic mammary gland somebody after fate of prior chemotherapy, locally advanced or metastatic non-small cell lung star sign, and prostate star sign.
Loratadine/Pseudoephedrine (Claritin-D) for Symptom Due to Colds
Adverse events included traveler diarrhea lasting two days that generally resolved without rescue drug or idiom interval.
A 13-month denotation country opus showed tegaserod to be safe and well-tolerated with long-term use.
Tegaserod was previously approved by the FDA in July 2002 for the short-term handling of irritable bowel symptom in women whose heavenly body bowel indicant is irregularity.
It is currently under composition for use in gastroesophageal ebb disease and dyspepsia.
Docetaxel (Taxotere) as Adjuvant in Direction of Node-Positive Mamma Planetary house
On Aug. 18, the FDA approved a supplemental datum for docetaxel (Taxotere, made by Aventis Pharmaceuticals), allowing its use in unit with doxorubicin and cyclophosphamide in the adjuvant tending of operable node-positive external body part INSTANCE OF constellation.
This is a part of article FDA Drug and Style Approvals: Zelnorm, Taxotere, Merci Retriever, and Others Taken from "Generic Claritin (Loratadine)" Information Blog